Graymatter Labs employs innovative nootropics and plant-based substances.
Graymatter Labs has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Graymatter Labs's investors include APEX Capital, Venrex, Palette Ventures.
Graymatter Labs is headquartered in Chicago, United States.
Graymatter Labs employs innovative nootropics and plant-based substances.
Graymatter Labs is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Graymatter Labs — Funding & Investors." VCBacked, November 6, 2025, https://www.vcbacked.co/company/graymatter-labs. Accessed October 12, 2026.
VCBacked. (2025). Graymatter Labs — Funding & Investors. Retrieved October 12, 2026, from https://www.vcbacked.co/company/graymatter-labs
{{cite web |title=Graymatter Labs — Funding & Investors |url=https://www.vcbacked.co/company/graymatter-labs |website=VCBacked |access-date=October 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated